SequelSEC

Polomar Health Services, Inc. PMHS

Pharmaceutical Preparations · CIK 0001265521 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$3.17M
Fiscal year ended 2026-06-30
Operating income
-$9.36M
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

Valuation, from the filing

Public float$3.61MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float per share$0.13Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue5.6×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Pharmaceutical Preparations filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
Revenue YoY growth1002.0%96th
Net margin-1650.8%27th
Operating margin-1627.5%27th
SBC / revenue20.0%48th
Gross margin71.0%49th

Polomar Health Services, Inc. (PMHS) reported revenue of $3.17M and net income of -$9.46M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from Polomar Health Services, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Pharmaceutical Preparations.

Income

Polomar Health Services, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$3.17M
Cost of revenue$1.23M
Gross profit$1.94M
Operating income-$9.36M
Net income-$9.46M
Research & developmentUnavailable
Weighted-average diluted sharesUnavailable
Pretax incomeUnavailable
Income tax expenseUnavailable
Diluted EPSUnavailable
Selling, general & administrative$11.30M
General & administrative$10.48M
Selling & marketing$818.38K

Balance

Polomar Health Services, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalentsUnavailable
Total assets$814.73K
Current assets$781.25K
Total liabilities$1.87M
Current liabilitiesUnavailable
Total equity incl. NCI-$1.06M
Temporary (mezzanine) equityUnavailable
Inventory$99.05K
Accounts receivable$470.32K
GoodwillUnavailable
Long-term debtUnavailable
Accounts payableUnavailable

Cash flow

Polomar Health Services, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow-$6.96K
Capital expendituresUnavailable
Investing cash flowUnavailable
Financing cash flow$181.15K
Net change in cash$174.19K
Stock-based compensationUnavailable
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$9.27M

Derived

Polomar Health Services, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flowUnavailable
Gross margin61.1%
Operating margin-295.0%
FCF marginUnavailable
SBC / revenueUnavailable
Current ratioUnavailable
Revenue YoY growth7688.8%
Net margin-298.3%
R&D / revenueUnavailable
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open PMHS in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-14View SEC filing
10-Q · Filed 2026-06-01View SEC filing
10-K · Filed 2026-05-06View SEC filing
10-Q · Filed 2025-11-25View SEC filing
10-Q · Filed 2025-08-19View SEC filing
10-Q · Filed 2025-06-30View SEC filing

Companies in the same industry

AAGH AARD ABBV ABCL ABEO ABT ABUS ABVC ACAD ACET ACRS ACRV

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.